Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1988 Jun;35(6):711-26.
doi: 10.2165/00003495-198835060-00006.

Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring

Affiliations
Review

Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring

A Glynn-Barnhart et al. Drugs. 1988 Jun.

Abstract

Theophylline is an important antiasthmatic medication which has bronchodilator properties. With increased understanding of the relationships of serum theophylline concentration and effect, both adverse and beneficial, oral dosage forms were developed to provide consistent serum theophylline concentrations with the benefit of convenient dosage intervals for long term use. Since factors such as concurrent disease states, drug interactions and age have a profound effect on theophylline disposition, relatively sophisticated dosage guidelines have evolved. Theophylline is in fact a model drug for the application of pharmacokinetic principles to the individualization of a treatment regimen. The purpose of this discussion is to review the relationship of serum theophylline concentration and pharmacodynamic effect and the special properties of oral sustained release theophylline formulations, and to provide a practical approach to prescribing theophylline. Guidelines are provided on the use of serum theophylline concentrations to individualize the theophylline dose, with an analysis of available techniques to monitor theophylline.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Hosp Pharm. 1977 May;34(5):525-7 - PubMed
    1. Pediatrics. 1984 Oct;74(4):453-9 - PubMed
    1. Clin Pharmacol Ther. 1982 Mar;31(3):358-69 - PubMed
    1. Clin Pharmacol Ther. 1972 May-Jun;13(3):349-60 - PubMed
    1. Clin Allergy. 1985 May;15(3):253-9 - PubMed

MeSH terms